Hamermesh Joshua 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed Mar 26, 2008
Insider Transaction Report
Form 4
Hamermesh Joshua
VP Comm & Bus Development
Transactions
- Exercise/Conversion
Employee Stock Option (right to buy)
2008-03-24−8,334→ 16,666 totalExercise: $3.00Exp: 2015-07-01→ Common Stock (8,334 underlying) - Exercise/Conversion
Common Stock
2008-03-24$3.00/sh+8,334$25,002→ 16,667 total
Footnotes (1)
- [F1]The employee stock option, at the time of grant, covered 33,333 shares of common stock (the "Original Shares"), of which 75% are subject to vesting in equal annual installments over a four year period beginning on April 14, 2006. 25% of the Original Shares are subject to accelerated vesting upon successful completion of certain performance milestone objectives, all of which have become vested because the milestone objectives have been achieved. As of the filing date, a total of 20,833 of the Original Shares have vested, and 12,500 will vest in two equal portions on April 14, 2008 and April 14, 2009, respectively.